- Home
- SNSE vs FTEL Comparison
SNSE vs FTEL Comparison
Compare SNSE & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- FTEL
- Stock Information
- Founded
- SNSE 2005
- FTEL 2007
- Country
- SNSE United States
- FTEL Australia
- Employees
- SNSE N/A
- FTEL N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- SNSE Health Care
- FTEL
- Exchange
- SNSE Nasdaq
- FTEL Nasdaq
- Market Cap
- SNSE 10.8M
- FTEL 11.1M
- IPO Year
- SNSE 2021
- FTEL 2023
- Fundamental
- Price
- SNSE $8.17
- FTEL $0.74
- Analyst Decision
- SNSE Strong Buy
- FTEL
- Analyst Count
- SNSE 3
- FTEL 0
- Target Price
- SNSE $86.67
- FTEL N/A
- AVG Volume (30 Days)
- SNSE 12.9K
- FTEL 212.3K
- Earning Date
- SNSE 08-05-2025
- FTEL 07-22-2025
- Dividend Yield
- SNSE N/A
- FTEL N/A
- EPS Growth
- SNSE N/A
- FTEL N/A
- EPS
- SNSE N/A
- FTEL N/A
- Revenue
- SNSE N/A
- FTEL $4,990,695.00
- Revenue This Year
- SNSE N/A
- FTEL N/A
- Revenue Next Year
- SNSE N/A
- FTEL N/A
- P/E Ratio
- SNSE N/A
- FTEL N/A
- Revenue Growth
- SNSE N/A
- FTEL 29.02
- 52 Week Low
- SNSE $5.00
- FTEL $0.36
- 52 Week High
- SNSE $17.40
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- SNSE 50.67
- FTEL 71.16
- Support Level
- SNSE $8.76
- FTEL $0.47
- Resistance Level
- SNSE $9.27
- FTEL $0.78
- Average True Range (ATR)
- SNSE 0.52
- FTEL 0.06
- MACD
- SNSE -0.00
- FTEL 0.03
- Stochastic Oscillator
- SNSE 42.84
- FTEL 86.78
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.